PFS Partners’s United Therapeutics UTHR Stock Holding History

PFS Partners’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$45K	Buy	+83	New	+$42.9K	0.02%	215

Other funds holding UTHR

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Livforsakringsbolaget Skandia Stockholm, Sweden $3.02B AUM 43.19% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return

PFS Partners's UTHR Position: Q3 2026 in Review

PFS Partners opened a new position in United Therapeutics (UTHR) in Q3 2026: 83 shares worth $45K. The stake represents 0.02% of the portfolio and ranks #215 among its holdings.

150 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

PFS Partners held 83 shares of United Therapeutics worth $45K as of Q3 2026.
United Therapeutics was a new PFS Partners position in Q3 2026.
United Therapeutics made up 0.02% of PFS Partners's portfolio in Q3 2026, its #215 holding.
150 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on PFS Partners's 13F filing for Q3 2026, filed 21 Oct 2026.